Sandra Acosta

Visionary Life Sciences executive with 36+ years of experience leading pharma, biotech, and clinical research initiatives globally. Specialist in regulatory compliance (FDA, EMA, MHRA), CQV, cell and gene therapies, vaccine production, and capital project management. Proven ability to build high-performance global teams and drive innovation across US, Europe, LATAM, and APAC regions. Founder & CEO of Innova Scientific Solutions.

Passionate for science extends beyond traditional pharmaceuticals. A fervent advocate for the potential of Cell & Gene therapies, having played a key role in the validation of systems and equipment for Cell & Gene therapy manufacturing. Some of the work includes experience with monoclonal, autologous/allogeneic cell expansion, and viral vectors.

Sandra Acosta is the Founder and CEO of Innova Scientific Solutions, LLC. She has led major capital expansion projects exceeding $500M and pioneered Cell & Gene Therapy manufacturing validations. I’ve played a pivotal role in optimizing COVID-19 vaccine commercialization globally and guiding site remediations under FDA/EMA/MHRA oversight. A recognized keynote speaker (KENX, EURO Biotech Congress), Regulatory expertise (FDA, EMA, MHRA), operational leadership, and vision for advancing Life Sciences innovation. Fluent in English and Spanish, I bridge scientific rigor and business acumen to shape industry transformations.